BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2004
View Archived Issues
Aplidin enters phase II for hematological malignancies
Read More
Combunox approved for short-term management of acute moderate/severe pain
Read More
Extended indication for Fludara oral in Europe
Read More
Submission of Aryplase BLA
Read More
Early atherosclerotic coronary calcification may be pathogen-induced
Read More
ZD-0473 effective in chemotherapeutic-resistant human colorectal cancer cell lines
Read More
Treatment with recombinant diabody and thalidomide promising in preclinical model of lymphoma
Read More
New interferon shows potent antiviral and proliferative efficacy
Read More
Putative melatonin receptor agonist promising for treatment of glaucoma
Read More
Preliminary data on the immunogenicity of ChimeriVax-Dengue vaccine
Read More
AVI-4126 reported to improve outcome in patients undergoing PCI
Read More
Edaravone shows promise in the reduction of infarct size after AMI
Read More
Clinical evidence for the antihypertensive effects of rosiglitazone in type 2 diabetes
Read More
MultiHance receives FDA approval
Read More
Atacand approved in Europe for treatment of chronic heart failure
Read More
Orathecin NDA action date delayed by new data
Read More
Reliant to market newly approved Omacor in U.S.
Read More
Four patents covering new treatments of cancer
Read More
Novartis temporarily withdraws European application for Prexige
Read More
New formulations of tegaserod claimed by Novartis
Read More
Novartis researchers prepare parenteral formulations of mycophenolic acid
Read More
Kissei describes SGLT inhibitors in patent literature
Read More
Takeda scientists prepare MCH receptor antagonists for obesity, depression, and anxiety
Read More
Antiinflammatory agents in early development at Minophagen for pain, arthritis, etc.
Read More
Agents for the treatment of arthritis claimed by Sumitomo
Read More
Sankyo researchers prepare and test PTP inhibitors
Read More
FDA approves new indication for Nexium
Read More
